S P Crouch
Overview
Explore the profile of S P Crouch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
427
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crouch S
Med Device Technol
. 2001 Feb;
11(8):12-5.
PMID: 11185180
This article reports on the potential use of adenosine triphosphate bioluminescence for fast and highly sensitive biocompatibility screening. Results suggest that this technology can be a useful tool for the...
2.
Bradbury D, Simmons T, Slater K, Crouch S
J Immunol Methods
. 2000 Jun;
240(1-2):79-92.
PMID: 10854603
In this study the relative levels of ADP and ATP have been measured in cells undergoing apoptosis. Using HL60, CEM7, Jurkat and U937 cell lines and cytotoxic agents known to...
3.
Turzanski J, Crouch S, Andrews M, Rose M, Finch R, Burden R, et al.
Br J Haematol
. 1998 Nov;
103(2):387-96.
PMID: 9827910
End-stage renal failure (ESRF) patients undergoing continuous ambulatory peritoneal dialysis (CAPD) are immunocompromised and exhibit abnormal circulating polymorphonuclear leucocyte (PMN) function, including reduced phagocytosis and intracellular killing. Six uraemic patients...
4.
Turzanski J, Crouch S, Fletcher J, Hunter A
Br J Haematol
. 1997 Jan;
96(1):46-54.
PMID: 9012686
Granulocyte colony-stimulating factor (G-CSF) is being considered as adjuvant treatment for infections in non-neutropenic patients. Normal healthy donors were given rHuG-CSF (Lenograstim) at 2.5, 5.0 and 7.5 micrograms/kg subcutaneously daily...
5.
Crouch S, Crocker I, Fletcher J
J Immunol
. 1995 Dec;
155(11):5436-43.
PMID: 7594561
Pregnancy exerts suppressive effects on a number of chronic inflammatory conditions, particularly rheumatoid arthritis. We isolated peripheral blood polymorphonuclear leukocytes (PMN) from pregnant women at 30 to 34 wk (n...
6.
Daniels I, Crouch S, Lindsay M, Morgan A, BURDEN R, Fletcher J
Clin Diagn Lab Immunol
. 1994 Mar;
1(2):227-31.
PMID: 7496950
Peritoneal dialysis effluent from patients with end-stage renal failure contains a low-molecular-weight solute that inhibits the killing of phagocytosed Staphylococcus epidermidis by polymorphonuclear leukocytes (PMN). This observation has been investigated...
7.
Crouch S, Kozlowski R, Slater K, Fletcher J
J Immunol Methods
. 1993 Mar;
160(1):81-8.
PMID: 7680699
Adenosine triphosphate (ATP) bioluminescence was used to determine whether there was a linear relationship between cultured cell number and measured luminescence using the luciferin-luciferase reaction. In all the cells tested...
8.
Crouch S, Fletcher J
Infect Immun
. 1992 Nov;
60(11):4504-9.
PMID: 1356929
Superoxide and other oxygen radicals produced by activated polymorphonuclear leukocytes (PMN) may be important causes of tissue damage in a number of inflammatory conditions. Therefore, a drug which suppresses PMN...
9.
Crouch S, Slater K, Fletcher J
Blood
. 1992 Jul;
80(1):235-40.
PMID: 1535239
The iron-binding protein lactoferrin (Lf) is a constituent of neutrophil secondary granules and is discharged into the surrounding medium when neutrophils are activated. Lf released from neutrophils phagocytosing opsonized particles...